CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomasJoseph Flores‐Toro, Jeffrey K. Harrison, Adithya Gopinath et al.|Proceedings of the National Academy of Sciences|2019Cited by 330
Cutting Edge: Developmental Switches in Chemokine Responses During T Cell MaturationJames J. Campbell, Eugene C. Butcher|The Journal of Immunology|1999Cited by 236